Cantor Fitzgerald and William Blair acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVRA:
- Zevra Therapeutics Announces Pricing of Underwritten Offering of Common Stock
- Zevra Therapeutics Announces Proposed Public Offering of Common Stock
- Zevra Therapeutics to Present at Canaccord Genuity’s 44th Annual Growth Conference
- Zevra Therapeutics price target raised to $18 from $15 at H.C. Wainwright
- FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C